Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| cancer hopkins johns prostate |
|
Johns Hopkins University School of Medicine: Information and Much The East Baltimore campus of Johns Hopkins University is home to the School of . Cancer Treatments Learn about current and promising cancer treatments. Prostate-Help: Johns Hopkins - Brady Urological Institute Johns Hopkins - Brady Urological Institute- Prostate Cancer Update. Link: Johns Hopkins - Brady Urological Institute- Prostate Cancer Update. The Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Johns Hopkins Medicine: The Sidney Kimmel Comprehensive Cancer Center Myeloma, Ovary, Pancreas, Paroxysmal Nocturnal Hemoglobinuria, Pharynx, Prostate Johns Hopkins Researchers Present Advances In Prostate Cancer Ciphergen Biosystems,Inc. (Nasdaq: CIPH) announced the discovery of two biomarkers that may aidin the management of prostate cancer, including for the EARLIER USE OF PROSTATE CANCER VACCINES URGED BY HOPKINS SCIENTISTS Johns Hopkins Medicine Office of Corporate Communications In the Hopkins studies with mice bred to develop prostate cancer, Drake and his collaborators NEW TEST FOR EARLY DETECTION OF PROSTATE CANCER SHOWS PROMISE Johns Hopkins Medicine Office of Corporate Communications called EPCA or early prostate cancer antigen, can successfully detect prostate cancer in its Prostate Cancer: No One Answer for Testing or Treatment No One Improved screening tests and treatments for prostate cancer in very early But "nerve sparing" techniques developed at Johns Hopkins University have Wake Forest-Johns Hopkins Team Discovers Prostate Cancer Gene Scientists in the Center for Human Genomics at Wake Forest University School of Medicine and Johns Hopkins Medical Institutions have discovered a gene that Gleason's Grading of Prostate Needle Biopsies The Gleason's grade of a prostate needle biopsy has important clinical implications, The Johns Hopkins Hospital. Baltimore, Maryland USA Prostate-Help: Johns Hopkins Prostate Cancer Treatment Special Link: Johns Hopkins Prostate Cancer Treatment Special Report Released. The specialists at Johns Hopkins's world-renowned James Buchanan Brady Urological Johns Hopkins Health Alerts Free Prostate Cancer Report Available Johns Hopkins Health Alerts, the consumer health information website published by University Health Publishing in conjunction with Johns Hopkins Medicine, Prescriptions, health, personal care cancer hopkins johns prostate cancer hopkins johns prostate headlines from likely prostate cancer charity minimizing they approximately common including to moderate obj can obj are smoke Johns Hopkins Gazette | April 30, 2007 New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2, or EPCA-2, may change the way men are screened for Johns Hopkins Gazette | September 26, 2005 PSA Best Indicator of Prostate Cancer Progression. By Eric Vohr Johns Hopkins Medicine. Despite recent claims by some urologists that measuring the blood The Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Physicians hope to learn more about the incidence and risks of the disease through a registry of all Johns Hopkins prostate cancer patients, which has been Brady Urological Institute - Johns Hopkins Hospital The Brady Urological Institute of Johns Hopkins Hospital is dedicated to providing H. Ballentine Carter About Prostate Cancer · Expectant Management Johns Hopkins - Brady Urological Institute- Prostate Cancer Discovery Prostate Cancer Discovery -A PUBLICATION OF THE PATRICK C.WALSH PROSTATE CANCER RESEARCH FUND. Johns Hopkins White Papers: Prostate Disorders Index New research: Does calcium help prevent prostate cancer, or put you at greater risk? The Johns Hopkins prostate cancer risk-reduction program: A 2-pronged Prostate Disorders, Prostate Cancer, BPH | Benign Prostatic Johns Hopkins Health Alerts: Prostate Disorders provides the latest research on the diagnosis and treatment of Benign Prostatic Hyperplasia (BPH), |
| cancer hopkins johns prostate |
|
dynamic photo prostate therapy caffeine prostate chemo for prostate cancer cancer clinical trial result prostate |